Temozolomide and Radiation Therapy in Treating Patients With Gliomas
Phase 2 Completed
136 enrolled 9 charts
G-FORCE-1
Phase 1 Completed
19 enrolled
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
Phase 1 Completed
28 enrolled
TAVAREC
Phase 2 Completed
155 enrolled
Temozolomide in Treating Patients With Low-Grade Glioma
Phase 2 Completed
120 enrolled 8 charts
Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma
Phase 2 Completed
29 enrolled
Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma
Phase 1 Completed
Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma
Phase 1 Completed
Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
Phase NA Completed
66 enrolled 13 charts
Temozolomide in Treating Patients With Recurrent High-Grade Glioma
Phase 2 Completed
60 enrolled 9 charts
Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
Phase 2 Completed
1 enrolled
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
Phase 1/2 Completed
257 enrolled 16 charts
The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)
Phase 2 Completed
120 enrolled 6 charts
Radiation Therapy or Temozolomide in Treating Patients With Gliomas
Phase 3 Completed
709 enrolled
Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial
Phase 2 Completed
23 enrolled
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Phase 2 Completed
47 enrolled 7 charts
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
Phase 1 Completed
22 enrolled
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors
Phase 1 Completed
Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
Phase 1 Completed
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
Phase 2 Completed
100 enrolled
ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
Phase 1 Completed
31 enrolled
Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma
Phase 1 Completed
61 enrolled
Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
Phase 2 Completed
25 enrolled 5 charts
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
Phase 1 Completed
72 enrolled
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
Phase 1/2 Completed
30 enrolled
Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors
Phase 2 Completed
Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma
Phase 1 Completed
Temozolomide in Treating Patients With Recurrent Malignant Glioma
Phase 2 Completed
Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma
Phase 1 Completed
Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
Phase 1 Completed
65 enrolled
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
Phase 1 Completed
25 enrolled
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
Phase 2 Completed
39 enrolled
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
Phase 1 Completed
26 enrolled
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
Phase 2 Completed
29 enrolled
Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
Phase 2 Completed
53 enrolled
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer
Phase 1 Completed
Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma
Phase 1 Completed
18 enrolled
Prolonged Daily Temozolomide for Low-Grade Glioma
Phase 2 Completed
46 enrolled
NOA-04
Phase 3 Completed
318 enrolled